These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1057841)

  • 1. [Effect of hydroxyurea treatment on free nucleotides in leukemic leukocytes].
    Maj S; Zdebska E
    Acta Haematol Pol; 1975; 6(3):211-6. PubMed ID: 1057841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Free nucleotides of normal and leukemic leukocytes].
    Maj S
    Acta Haematol Pol; 1972; 3(4):323-31. PubMed ID: 4526501
    [No Abstract]   [Full Text] [Related]  

  • 3. DNA repair in human leukemic leucocytes treated with neocarzinostatin.
    Sasada M; Sawada H; Nakamura T; Uchino H
    Gan; 1978 Jun; 69(3):407-12. PubMed ID: 149685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy with hydroxyurea, leucopheresis and splenectomy in the treatment of chronic myeloid leukemia at the problastic phase.
    Schwarzenberg L; Mathe G; Pouillart P; Weiner R; Lacour J; Genin J; Schneider M; de Vassal F; Hayat M; Amiel JL; Schlumberger JR; Jasmin C; Rosenfeld C
    Haematologica; 1972 Apr; 57(11):601-11. PubMed ID: 4200296
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metabolism of nucleotides and RNA in leukocytes in chronic myeloleukosis].
    Filanovskaia LI; Vartanian NL; Ushakova EA; Blinov MN
    Vopr Med Khim; 1983; 29(4):73-7. PubMed ID: 6578634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea in the prevention of the effects of leukostasis in acute leukemia.
    Grund FM; Armitage JO; Burns P
    Arch Intern Med; 1977 Sep; 137(9):1246-7. PubMed ID: 268956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free nucleotides of normal and leukemic leukocytes.
    Maj S
    Acta Med Pol; 1973; 14(3):217-32. PubMed ID: 4518050
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxyurea (Biosupressin-BIOGAL) for the treatment of chronic myelogenous leukaemia.
    Klener P; Donner L
    Ther Hung; 1981; 29(1):38-41. PubMed ID: 6964902
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of chronic myeloid leukemia with hydroxyurea].
    Djaldetti M
    Harefuah; 1971 Nov; 81(9):438-41. PubMed ID: 5291276
    [No Abstract]   [Full Text] [Related]  

  • 10. [Free nucleotides of normal leukocytes and leukocytes in chromic leukemia].
    Maj S; Zdebska E; Daszyński J; Radziszewski J
    Acta Haematol Pol; 1972; 3(2):111-8. PubMed ID: 4144096
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences in the treatment of chronic myeloid leukemia].
    Pensabene A; Panzacchi G; Cipriani D
    Haematologica; 1971; 56(3):163-8. PubMed ID: 5003589
    [No Abstract]   [Full Text] [Related]  

  • 12. Enzyme activities and deoxynucleoside utilization of leukemic leukocytes in relation to drug therapy and resistance.
    Roberts D; Hall TC
    Cancer Res; 1969 Jan; 29(1):166-73. PubMed ID: 5249740
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon production by human leukaemic leucocytes.
    Hadházy G; Fekete B; Szabó G; Szabó B
    Acta Microbiol Acad Sci Hung; 1976; 23(1):15-22. PubMed ID: 180756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Leukemic transformation of polycythemia vera after treatment with hydroxyurea and chromosome 17 abnormalities].
    Tóthová E; Nebesnáková E; Kafková A; Stecová N; Fricová M
    Vnitr Lek; 1999 Aug; 45(8):487-9. PubMed ID: 11045151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial of hydroxyurea in chronic myelocytic leukemia.
    Baudo F; Cattaneo N; Cipriani D; De Cataldo F; Pensabene A; Tiso R
    Haematol Lat; 1967; 10(4):359-62. PubMed ID: 5243231
    [No Abstract]   [Full Text] [Related]  

  • 16. Skin changes secondary to hydroxyurea therapy.
    Kennedy BJ; Smith LR; Goltz RW
    Arch Dermatol; 1975 Feb; 111(2):183-7. PubMed ID: 1054261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs in the treatment of leukemia.
    Br Med J; 1968 Nov; 4(5626):305-7. PubMed ID: 5246597
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxyurea as a cause of drug fever in chronic myeloid leukaemia.
    Blonk MC; Ossenkoppele GJ
    Neth J Med; 1988 Jun; 32(5-6):240-2. PubMed ID: 3164836
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of hydroxyurea (Biosuppressin) in the accelerated phase of chronic myeloid leukemia].
    Kiss A; Jakó J; Rák K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):275-80. PubMed ID: 6168539
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I study using combination of hydroxyurea and 5-azacytidine (NSC-102816).
    Lomen PL; Khilanani P; Kessel D
    Neoplasma; 1980; 27(1):101-6. PubMed ID: 6154898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.